Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
BMC Cancer|April 25, 2024
A qualitative evaluation of factors influencing Tumor Treating fields (TTFields) therapy decision making among brain tumor patients and physiciansPriya Kumthekar, Madison Lyleroehr, Leilani Lacson, et al.
Communications Medicine|February 10, 2026
Assessments of social vulnerability on central nervous system cancer disparities in the United StatesDavid J Fei-Zhang, Salim C Lutfallah, Joshua Mensah, et al.
Science Advances|May 17, 2023
Ribonucleotide reductase regulatory subunit M2 drives glioblastoma TMZ resistance through modulation of dNTP productionElla N Perrault, Jack M Shireman, Eunus S Ali, et al.
Journal of Clinical Medicine|September 27, 2025
Intracranial Metastases from Uterine Leiomyosarcoma: A Systematic Review and Case IllustrationAhmad Pour-Rashidi, Sara Zandpazandi, Laetitia Perronne, et al.
Acta Neuropathologica Communications|November 3, 2023
Variant allelic frequencies of driver mutations can identify gliomas with potentially false-negative MGMT promoter methylation resultsMatthew McCord, Pouya Jamshidi, Vineeth Thirunavu, et al.
Neuro-Oncology|August 10, 2022
A phase I/II study of intrathecal trastuzumab in human epidermal growth factor receptor 2-positive (HER2-positive) cancer with leptomeningeal metastases: Safety, efficacy, and cerebrospinal fluid pharmacokineticsPriya U Kumthekar, Michael J Avram, Andrew B Lassman, et al.
The Lancet. Oncology|May 4, 2023
Repeated blood-brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: a phase 1 trialAdam M Sonabend, Andrew Gould, Christina Amidei, et al.
Research Square|October 3, 2025
Newly diagnosed glioblastoma IDHwt patients treated with radiation, nivolumab, and BMS-986205Derek Wainwright, Rimas Lukas, Lijie Zhai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2020
Advanced Age Increases Immunosuppression in the Brain and Decreases Immunotherapeutic Efficacy in Subjects with GlioblastomaErik Ladomersky, Lijie Zhai, Kristen L Lauing, et al.
Nature Communications|December 16, 2025
Dynamic release of extracellular particles after opening of the blood-brain barrier predicts glioblastoma susceptibility to paclitaxelMark W Youngblood, Abha Kumari, Yoon-Tae Kang, et al.
Pageof 4